Información*
| Nombre | LAURA HERNANDEZ PADILLA |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS BIOMÉDICAS |
| Disciplina | BIOLOGÍA CELULAR |
| Especialidad | CANCER |
| CVU | 415990 |
| Institución | |
|---|---|
| Dependencia | NO APLICA |
| Entidad | NO APLICA |
| Nivel | C |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2026 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2026
- Cyclodipeptides Reversed Liver Damage and Adipose Tissue Dysfunction in a Chronic Obesity MASLD Rat Model by Remodeling White Adipocytes Toward a Beige-like Adipocyte Phenotype Molecules
- Bacterial Cyclodipeptides Inhibit Invasiveness and Metastasis Progression in the Triple-Negative Breast Cancer MDA-MB-231 Mouse Model Molecules
- Bacterial Cyclodipeptides Inhibit Invasiveness and Metastasis Progression in the Triple-Negative Breast Cancer MDA-MB-231 Mouse Model
- 2025
- Anti-metastatic Properties of Bacterial Cyclodipeptides are Potentialized with Methotrexate in Xenotransplant Mice Model of the Triple-negative Breast Cancer MDA-MB-231 Line
- Anti-metastatic Properties of Bacterial Cyclodipeptides are Potentialized with Methotrexate in Xenotransplant Mice Model of the Triple-negative Breast Cancer MDA-MB-231 Line
- The HGF/Met Receptor Mediates Cytotoxic Effect of Bacterial Cyclodipeptides in Human Cervical Cancer Cells Current Cancer Drug Targets
- 2024
- Cyclic Peptides as Protein Kinase Modulators and Their Involvement in the Treatment of Diverse Human Diseases Kinases and Phosphatases
